Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, its participation in the American Society of Gene & Cell Therapy (ASGCT).

25th Annual Meeting to be held in Washington, D.C. from May 16-19, 2022, at which Factor ...

PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, the appointment of Meredith Manning to President of the ...

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, it dosed the first set of volunteers in an open-label study of AKS-452, its protein subunit COVID-19 vaccine, as a booster.

The Phase II booster study is designed to investigate the response of the immune ...

BMG LABTECH introduced the new VANTAstar™ microplate reader, further expanding its range of high-quality, made-in-Germany instruments.

The latest addition to the BMG LABTECH portfolio, the VANTAstar was conceived for ease-of-use and flexibility for a wide range of applications in basic research ...

At the ISMRM 2022 conference, Bruker the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio.

Following the success of its BioSpec® Maxwell 3 Tesla model, the new range of Maxwell 7 ...

STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies targeting RNA epigenetic mechanisms.

That it has been awarded a Biomedical Catalyst grant by Innovate UK to research and develop new drugs directed against a unique SARS-CoV2 protein utilizing ...